Assenagon Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-61,563
Closed -$5.63M 1377
2023
Q2
$5.63M Buy
61,563
+36,300
+144% +$2.98M 0.02% 473
2023
Q1
$1.86M Sell
25,263
-46,222
-65% -$4M 0.01% 861
2022
Q4
$5.97M Sell
71,485
-92,843
-56% -$8.37M 0.02% 500
2022
Q3
$15.9M Buy
164,328
+122,588
+294% +$14.6M 0.06% 268
2022
Q2
$4.39M Buy
+41,740
New +$5.33M 0.02% 587
2021
Q4
Sell
-98,435
Closed -$14.7M 1416
2021
Q3
$14.7M Buy
98,435
+54,747
+125% +$11.4M 0.05% 244
2021
Q2
$10.7M Sell
43,688
-11,169
-20% -$2.93M 0.04% 329
2021
Q1
$14.5M Buy
54,857
+38,887
+244% +$11M 0.06% 262
2020
Q4
$4.68M Sell
15,970
-182,832
-92% -$46.9M 0.02% 364
2020
Q3
$47M Buy
+198,802
New +$45.2M 0.26% 67
2020
Q2
Sell
-2,683
Closed -$492K 1108
2020
Q1
$492K Buy
+2,683
New +$477K ﹤0.01% 644
2019
Q3
Sell
-61,038
Closed -$7.41M 826
2019
Q2
$7.41M Buy
+61,038
New +$7.24M 0.06% 209
2019
Q1
Sell
-49,306
Closed -$5.77M 930
2018
Q4
$5.77M Buy
49,306
+29,262
+146% +$3.45M 0.07% 217
2018
Q3
$2.5M Buy
+20,044
New +$2.21M 0.02% 469
2018
Q1
Sell
-51,796
Closed -$2.73M 542
2017
Q4
$2.73M Buy
51,796
+30,142
+139% +$1.59M 0.03% 399
2017
Q3
$1.21M Buy
+21,654
New +$1.15M 0.01% 366

Other funds holding AMED

Assenagon Asset Management's AMED Position: Q3 2023 in Review

Assenagon Asset Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 61,563 shares — an estimated $5.63M sold.

Assenagon Asset Management first reported a position in AMED in Q3 2017 and held it in 16 quarters. The position peaked at $47M in Q3 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Assenagon Asset Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 61,563 Amedisys shares in Q3 2023, an estimated $5.63M.
  • Assenagon Asset Management first reported a position in Amedisys in Q3 2017 and held it in 16 quarters.
  • Assenagon Asset Management's Amedisys position peaked at $47M in Q3 2020.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Assenagon Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.